European Pharmaceutical Review

APRIL 17, 2023

A report on automation in the biopharma industr y has shown that the market is projected to grow at a compound annual growth rate (CAGR) of 5.7 Factors impacting the automation in the biopharma industry market The report found that 75 percent of pharmaceutical organisations want to use automated solutions more frequently.

Biopharma 88

Biopharma Manufacturing Pharmaceutical products Marketing 88

Clarivate

MARCH 14, 2024

These molecules of interest also impacted the pharmaceutical industry, and pharmaceutical companies faced a requirement to rapidly adopt risk mitigation plans to monitor the presence of nitrosamines in drug products. However, this regulatory ban does not impact active pharmaceutical ingredients (APIs).

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

Pharmaceutical Technology

DECEMBER 20, 2022

Now, Pfizer will lead all the development, commercialisation activities as well as costs for the RSV therapeutic candidate in the regions. In 2020, LianBio and Pfizer partnered to develop and commercialise transformative pharmaceutical products in Greater China.

Biopharma 64

Biopharma Pharmaceutical products Patients Pharmaceutical 64

pharmaphorum

SEPTEMBER 28, 2022

In recent years, the biopharma market has become progressively complex. As a result, payers are feeling increased pressure to make the right decisions based on the perceived value of each product. HTA agencies can assist biopharma companies at the early stages of development to ensure they are meeting the expectations of payers.

Biopharma 52

Biopharma Side effects Consulting Pharmaceutical products 52